11-Point Bedside Verification Checklist
Group & Screen vs Crossmatch
TestWhat It ChecksWhen Used
Group & ScreenABO/Rh typing + antibody screen (no blood held)Elective low-risk surgery, routine admission
Electronic CrossmatchComputer-verified compatibility using 2 historical groupsCommon in GCC JCI hospitals with LIMS
Serological CrossmatchPhysical mixing of patient serum + donor cellsPositive antibody screen, previous transfusion reaction
Emergency UncrossmatchedO-negative RBCs issued without testingLife-threatening haemorrhage, no time for testing
Sample Labelling Requirements
  • 1
    Patient full name (as per ID)
    Must be handwritten at bedside — no pre-labelled tubes.
  • 2
    Date of birth + MRN
    Both identifiers required per CBAHI/JCIA standard.
  • 3
    Date, time, and collector signature
    Sample is invalid after 72 hours in most GCC institutions.
  • 4
    Ward/location
    Enables blood bank to return unit to correct location.
Two-Nurse Checking Policy

Two qualified nurses (or one nurse + one other authorised checker per local policy) must independently verify all 11 points at the bedside before administration. Both must sign the transfusion record.

GCC Practice Note: Many GCC hospitals require both checkers to be Registered Nurses. One may be the administering nurse; the second is an independent verifier. Checking cannot be done remotely or by phone — both must be physically present at the bedside.

Electronic Issue (EI) Systems: Barcode scanners linked to the EMR provide an additional safety layer. The system will alert on any mismatch before administration. EI does not replace the two-nurse check — it supplements it.

Verbal Consent Process
  1. Explain the clinical reason for the transfusion in the patient's language (interpreter if needed).
  2. Describe the procedure — IV cannula, drip, monitoring requirements.
  3. Discuss benefits, risks (reactions, infection transmission), and alternatives.
  4. Allow time for questions and answer fully.
  5. Document consent in the EMR or on the transfusion consent form.
  6. If patient cannot consent — follow mental capacity/guardian policy per GCC jurisdiction.
  7. For Jehovah's Witness — document advance directive; notify physician and obtain legal advice if urgent.
Wristband: Patient must wear a correctly labelled identity wristband throughout transfusion. Non-wristbanded patients must not receive blood — replace wristband first.
Packed Red Blood Cells (PRBCs)
ParameterValue
Standard IndicationHb <70 g/L (symptomatic)
Cardiac PatientsHb <80 g/L (ischaemic heart disease, cardiac surgery)
Volume per unit~250–350 mL
Expected Hb rise~10 g/L per unit in adults
Infusion rateOver 2–4 hours per unit
Maximum hang time4 hours from leaving blood bank fridge
Set changeNew blood giving set each unit (or per policy, max 12h)
Restrictive Strategy: Transfuse one unit, recheck Hb before second unit unless haemodynamically unstable (NICE/AABB evidence-based guideline).
Fresh Frozen Plasma (FFP)
ParameterValue
IndicationINR >1.5 with active bleeding or before invasive procedure
Alternative4-Factor PCC (Beriplex/Octaplex) — faster, lower volume
Dose15–20 mL/kg (typically 3–4 units adult)
Volume per unit~200–250 mL
Infusion rateOver 30 minutes per unit (adult)
Thaw time~30 min — plan ahead; once thawed, 24h shelf life (4°C)
ABO compatibleRequired; Rh matching not mandatory for FFP
4-Factor PCC Advantage: Contains Factors II, VII, IX, X. Preferred for warfarin reversal in GCC critical care — smaller volume, faster onset, no thaw delay.
Platelets
ThresholdIndication
<10 × 10⁹/LProphylactic transfusion — prevent spontaneous bleeding
<20 × 10⁹/LPatient with fever, infection, or on antibiotics
<50 × 10⁹/LBefore most invasive procedures / surgery
<100 × 10⁹/LNeurosurgery or ophthalmic surgery
Any levelActive bleeding with impaired platelet function

Administration

  • Infuse over 20–30 minutes; use a platelet-compatible giving set
  • Do NOT refrigerate platelets — store at 20–24°C with constant agitation
  • ABO-compatible preferred; Rh-negative for women of childbearing age
  • Shelf life: 5–7 days from collection (varies by GCC blood bank)
Cryoprecipitate & Other Components

Cryoprecipitate

  • Indication: Fibrinogen <1.5 g/L with bleeding; DIC
  • Also contains Factor VIII, XIII, vWF, fibronectin
  • Dose: 2 pools (10 units) raises fibrinogen by ~1 g/L
  • Infuse over 15–30 minutes via blood giving set

Granulocytes

  • Rarely used; reserved for life-threatening neutropenic sepsis unresponsive to antibiotics
  • Must be irradiated; ABO and Rh compatible
  • Infuse within 24h of collection; very short shelf life

Albumin

  • 4% (iso-oncotic): volume replacement in sepsis, SBP
  • 20–25% (hyperoncotic): hypoalbuminaemia with oedema
  • No crossmatch required; virus-inactivated pooled product
CMV-Negative & Irradiated Blood — Indications

CMV-Negative Blood

  • Pregnant women (to protect foetus)
  • CMV-seronegative immunocompromised patients (bone marrow/solid organ transplant recipients)
  • HIV-positive, CMV-seronegative patients
  • Premature neonates (<1,500g birth weight)
  • Note: Leucodepletion is an acceptable alternative to CMV-negative in most GCC hospitals — all donated blood in UAE and Saudi Arabia is leucodepleted

Irradiated Blood

  • Prevents transfusion-associated graft-versus-host disease (TA-GvHD) — a rare but fatal complication
  • Indications: severe combined immunodeficiency (SCID), bone marrow transplant (all phases), Hodgkin lymphoma, intrauterine transfusion, neonatal exchange transfusion, directed donations from relatives
  • In GCC: irradiation service available at major tertiary hospitals (King Faisal Specialist Hospital, Cleveland Clinic Abu Dhabi, Hamad Medical Corporation)
  • Irradiated red cells expire earlier — use promptly
Observation Schedule & Parameters
Baseline
Before transfusion starts — Temperature, BP (systolic + diastolic), Heart Rate, Respiratory Rate, SpO₂, Urine output (if indicated). Document in transfusion record.
0–15 minutes
1:1 nursing required. Repeat all vital signs at 15 minutes. Remain at bedside throughout first 15 minutes. This is the highest risk window for acute haemolytic reactions.
1 hour
Repeat full vital signs at 1 hour post-start. Assess for flank pain, urticaria, dyspnoea, fever (>1°C rise from baseline), rigors.
End of Unit
Record completion time, volume transfused. Repeat full vital signs. Document in EMR. Dispose of empty bag as per GCC hospital biohazard policy (or retain 24h for reaction investigation).
Any Time
If ANY adverse sign → stop transfusion, keep IV line open with normal saline, call for help. Do NOT remove cannula.
Infusion Rate Guidelines
ComponentStandard RateMaximum Hang Time
PRBCs (packed red cells)Over 2–4 hours4 hours from leaving blood bank
FFPOver 30 minutes4 hours once thawed (30 min preferred)
PlateletsOver 20–30 minutes30 minutes
CryoprecipitateOver 15–30 minutes4 hours once thawed
PRBCs (cardiac risk)Over 4 hours (slower)4 hours — request split if needed
30-Minute Rule: Blood must be hung within 30 minutes of leaving the blood bank fridge. If this window is exceeded, return the unit to the blood bank — do NOT transfuse.
Monitoring Parameters
  • T
    Temperature
    Rise of ≥1°C from baseline is significant. Febrile reactions are the most common.
  • BP
    Blood Pressure
    Hypotension = haemolytic/anaphylactic/bacterial reaction until proven otherwise.
  • HR
    Heart Rate
    Tachycardia with fever/hypotension — escalate immediately.
  • SpO₂
    Oxygen Saturation
    SpO₂ drop >3% — consider TRALI or TACO. Apply O₂ and escalate.
  • UO
    Urine Output / Colour
    Pink/red/dark urine = haemoglobinuria — suspect haemolytic reaction. Stop transfusion.
Documentation in GCC EMR Systems

Pre-Transfusion Record

  • Two-nurse check names & signatures
  • Unit number, blood group, expiry
  • Consent status
  • Baseline vital signs
  • Cannula site and gauge
  • Start time

During Transfusion

  • 15-min obs with timestamp
  • 1-hour obs
  • Patient responses/complaints
  • Any rate adjustments
  • IV site assessment
  • Nursing interventions

Post-Transfusion

  • End time & volume infused
  • End-of-unit vital signs
  • Post-transfusion Hb result (if ordered)
  • Any reactions reported
  • Blood bank notification if reaction
  • Bag disposal method
GCC EMR Note: Systems such as Cerner (widely used in UAE/Qatar), MEDITECH, and PHAMIS/LastWord are common in GCC hospitals. All transfusion events must be documented in real time. Paper backup forms are required when EMR is down.
Returning Unused Blood

A unit of blood that was not transfused must be returned to the blood bank within 30 minutes of leaving the controlled fridge environment. The blood bank will assess if it can be re-issued based on cold chain documentation. Nurses must never store blood in ward fridges unless the ward has a validated, monitored blood storage fridge that meets blood bank standards.

Never: Place blood in a ward medication fridge, ice bucket, or leave at room temperature >30 minutes. This breaches cold chain integrity and is a patient safety incident requiring reporting.
SHOT Principle — All reactions must be reported: Serious Hazards of Transfusion (SHOT) is the UK haemovigilance system widely adopted as a standard in GCC. All adverse events must be reported to the blood bank and the GCC national haemovigilance authority (e.g., Saudi FDA, UAE Ministry of Health).
Reaction Management Algorithms

1. Acute Haemolytic Reaction (ABO Incompatibility)

Onset: Within minutes. Mortality risk: High.

Signs: Fever, rigors, hypotension, flank/back pain, haemoglobinuria (red/dark urine), DIC, renal failure.

STOP TRANSFUSION IMMEDIATELY
  • STOP transfusion — clamp blood line, keep IV open with 0.9% NaCl
  • Do NOT remove cannula — may need for emergency drugs
  • Call physician STAT — code response if collapse
  • Repeat patient ID check vs blood unit — identify any mismatch
  • Notify blood bank — return blood bag, all lines, and giving set
  • Blood cultures, repeat G&S and crossmatch, FBC, coag, renal panel, LFTs, haemolysis screen (LDH, haptoglobin, DAT)
  • Urine for haemoglobin; maintain urine output >1 mL/kg/hr — IV fluids
  • Incident report — haemovigilance report to national authority

2. Febrile Non-Haemolytic Reaction (FNHTR)

Onset: During or up to 4h after. Incidence: 0.5–1% of transfusions.

Signs: Fever (≥1°C rise), chills, rigors, mild headache. No haemolysis. No hypotension.

SLOW or STOP — assess severity
  • Stop transfusion temporarily; perform full assessment
  • Check vital signs — confirm no hypotension, SpO₂ drop, haemoglobinuria
  • Administer paracetamol 1g PO/IV as prescribed
  • If mild and physician confirms non-haemolytic — may restart at slower rate
  • Document fully; notify blood bank
  • Pre-medicate future transfusions with paracetamol ± antihistamine if recurrent

3. Allergic / Anaphylactic Reaction

Onset: Minutes (IgA deficiency = severe). Mild (urticaria only) vs severe (anaphylaxis).

Signs (mild): Urticaria, pruritus, flushing.
Signs (severe): Bronchospasm, stridor, hypotension, angioedema.

  • STOP transfusion
  • Mild: administer chlorphenamine (antihistamine) — may restart slowly if resolves
  • Severe/anaphylaxis: Adrenaline (epinephrine) 0.5mg IM (1:1000) — call emergency team
  • O₂ 15L via non-rebreather mask; IV fluids (crystalloid bolus)
  • Steroids (hydrocortisone 200mg IV) — secondary treatment
  • Notify blood bank; document; haemovigilance report
  • Investigate IgA deficiency if recurrent; use IgA-depleted blood

4. TRALI — Transfusion-Related Acute Lung Injury

Onset: Within 6 hours of transfusion. Commonly during or just after.

Signs: Acute hypoxia (SpO₂ <90% on room air), new bilateral pulmonary infiltrates on CXR, fever, hypotension. No pre-existing fluid overload.

STOP — Respiratory Emergency
  • STOP transfusion immediately
  • High-flow O₂ — may require non-invasive ventilation (CPAP/BiPAP) or intubation
  • Call ICU / rapid response team
  • CXR, ABG, FBC — bilateral infiltrates without cardiomegaly is hallmark
  • NO diuretics (unlike TACO — this is NOT fluid overload)
  • Supportive care; most resolve within 96 hours
  • Notify blood bank urgently — donor lookback required
  • SHOT/haemovigilance report mandatory

5. TACO — Transfusion-Associated Circulatory Overload

Onset: During or within 6 hours. Risk: elderly, cardiac/renal failure, rapid rates.

Signs: Dyspnoea, hypertension (vs hypotension in TRALI), tachycardia, peripheral oedema, raised JVP, bilateral crackles, new/worsening pulmonary oedema on CXR.

SLOW or STOP
  • Slow or stop transfusion; sit patient upright
  • O₂ therapy; furosemide IV as prescribed (key differentiator from TRALI)
  • Fluid balance; monitor response; repeat CXR
  • BNP/NT-proBNP elevated — supports TACO diagnosis
  • Future prevention: transfuse slowly (4h), furosemide between units in at-risk patients
  • Document and report

6. Bacterial Contamination / Transfusion-Transmitted Sepsis

Onset: Rapid — minutes to 1–2 hours. Higher risk with platelets (room-temp storage).

Signs: High fever (>39°C), rigors, rapid hypotension, tachycardia, collapse — septic shock pattern.

STOP — Septic Emergency
  • STOP transfusion immediately
  • Broad-spectrum IV antibiotics STAT (after blood cultures)
  • Blood cultures from patient AND from blood bag — send bag to blood bank
  • Sepsis bundle: fluids, vasopressors if needed, ICU referral
  • Blood bank quarantines all units from same donation
  • Mandatory SHOT/haemovigilance report

7. Delayed Haemolytic Reaction (DHTR)

Onset: 5–10 days post-transfusion. Cause: anamnestic antibody response to red cell antigen.

Signs: New anaemia, jaundice, fever, haemoglobinuria (mild). Often asymptomatic — detected on routine Hb check.

Management: Notify blood bank; repeat crossmatch with current sample; provide antigen-negative blood for future transfusions. Haemovigilance report.

Transfusion Reaction Response Guide

Select the symptom onset timing and presenting symptoms to identify the most likely reaction and generate immediate action steps.

Step 1 — When did symptoms appear?

Step 2 — Which symptoms are present? (check all that apply)

EMERGENCY — IMMEDIATE ACTION REQUIRED

Massive Transfusion Protocol (MTP)

Defined as transfusion of ≥10 units of red cells in 24 hours, or replacement of the entire blood volume within 24 hours, or transfusion of >4 units of red cells in 1 hour with ongoing haemorrhage.

1
RBC
:
1
FFP
:
1
Platelets
The 1:1:1 ratio (RBC:FFP:Platelets) is the evidence-based haemostatic resuscitation strategy for massive haemorrhage. This mimics whole blood and prevents the "lethal triad" of hypothermia, acidosis, and coagulopathy.

MTP Activation Criteria (typical GCC MTP)

  • Haemorrhagic shock unresponsive to initial resuscitation
  • Systolic BP <90 + HR >120 + active haemorrhage
  • ABC Score ≥2 (Assessment of Blood Consumption)
  • Clinical judgement by trauma/surgical team

MTP Nursing Actions

  • Activate MTP — designated phone number to blood bank
  • Two large-bore IVs (14–16G); consider rapid infuser / Level 1
  • Minimise hypothermia — blood warmer mandatory for massive transfusion
  • Labs every 30–60 min: FBC, coag, fibrinogen, TEG/ROTEM if available, Ca²⁺
  • Calcium supplementation (CaCl₂ or gluconate) — citrate toxicity in massive transfusion
  • Tranexamic acid (TXA) 1g IV over 10 min within 3 hours of injury
  • Document all units with time administered
Cell Salvage (Intraoperative / Postoperative)

Autologous technique — patient's own shed blood is collected, washed, and returned. Avoids donor blood risks.

Indications

  • Cardiac surgery (on-pump and off-pump)
  • Orthopaedic surgery (hip/knee arthroplasty, spinal)
  • Vascular surgery (aortic aneurysm repair)
  • Trauma — where contamination is not a concern
  • Jehovah's Witness patients — may accept if circuit is kept continuous

Nursing Role

  • Set up and label cell salvage collection system
  • Ensure processed blood is labelled with patient details
  • Re-infuse within 6 hours of processing
  • Document volume collected and re-infused
Autologous Pre-Donation

Patient donates their own blood before elective surgery for re-infusion. Less common in GCC due to logistics but available in major tertiary hospitals.

Eligibility

  • Elective surgery with expected significant blood loss
  • Hb ≥110 g/L before donation
  • No active infection or cardiovascular instability
  • Donated up to 5 weeks before surgery
Autologous blood is still subject to full compatibility testing and two-nurse check procedures.
Sickle Cell — Exchange Transfusion

Used for: acute stroke, acute chest syndrome (severe), priapism, pre-operative preparation in high-risk surgery.

Goal

  • Reduce HbS% to <30% (acute stroke) or <50% (others)
  • Maintain Hb 90–100 g/L (avoid hyperviscosity)

Extended Phenotype Matching

  • Match at minimum: C, E, Kell — reduces alloimmunisation risk
  • Frequent transfusers: additional Kidd, Duffy, S matching
  • GCC blood banks — request phenotypically matched blood proactively

Nursing Actions

  • Automated erythrocytapheresis (Spectra Optia) in specialist centres
  • Manual exchange: alternating venesection + PRBC transfusion
  • Haematology liaison required for complex exchanges
Neonatal Transfusion

Neonatal Top-Up Transfusion

  • Indication: Hb <100–120 g/L in symptomatic neonate, <70 g/L if stable preterm
  • Volume: 10–20 mL/kg PRBC over 3–4 hours
  • Use CMV-negative, irradiated, leucodepleted fresh blood (<7 days old preferred)
  • Microfilter giving set; volume control pump mandatory

Neonatal Exchange Transfusion

  • Indication: Severe haemolytic disease of newborn (HDN), hyperbilirubinaemia unresponsive to phototherapy
  • Reconstituted whole blood (RBCs + FFP) crossmatched against mother's serum
  • Double volume exchange: 160 mL/kg
  • Performed in NICU by neonatologist + specialist nurses
Jehovah's Witness — Clinical & Ethical Management

Advance Directive / Refusal

  • Competent adult JW patient has the legal right to refuse blood transfusion in all GCC jurisdictions
  • Advance Directive or "No Blood" card must be documented in EMR
  • Notify consultant, risk management, and hospital legal team
  • Document all discussions and decisions clearly
  • For children — complex legal and ethical considerations; court order may be sought in life-threatening situations

Blood Conservation Alternatives

  • EPO (Erythropoietin): Stimulates erythropoiesis — use pre-operatively for elective surgery
  • IV Iron: Correct iron deficiency without transfusion
  • Cell Salvage: Many JW patients accept if circuit is continuous and blood is not stored separately
  • Haemostatic surgical techniques: Argon beam coagulation, haemostatic agents, controlled hypotension
  • Tranexamic Acid: Reduces surgical blood loss by up to 40%
  • Haemodilution: Acute normovolaemic haemodilution — some JW accept
Blood Bank Accreditation Standards in GCC
StandardRelevance in GCC
AABB (American Assoc. of Blood Banks)Gold standard — major GCC tertiary hospitals (KFSH, Cleveland Clinic AD, Hamad Medical) hold AABB accreditation
CAP (College of American Pathologists)Laboratory accreditation — includes blood bank component; common in UAE and Saudi private hospitals
CBAHI (Saudi Arabia)Saudi Central Board for Accreditation of Healthcare Institutions — mandatory for Saudi hospitals; includes transfusion standards
JCIA (Joint Commission International)International accreditation — held by major hospitals in UAE, Qatar, Kuwait; strict transfusion chapter
ISO 15189Medical laboratory quality standard — many GCC blood banks use ISO 15189 in parallel
Blood Donation Landscape in GCC

Current Status

  • UAE: Abu Dhabi Blood Services (ADBS) and Dubai Blood Donation Centre coordinate voluntary donation. National campaigns during Ramadan and UAE National Day.
  • Saudi Arabia: Saudi National Blood Services Programme — drives in universities, malls, mosques during Hajj season.
  • Qatar: Hamad Medical Corporation Blood Donor Centre — highly structured voluntary donor program; blood adequacy for a small population.
  • Kuwait: Kuwait Blood Bank — primarily hospital-based; national donor recruitment growing.
  • GCC overall: expatriate donor pool is large and important. Challenge: high turnover of expat population affects regular donor retention.
Shortage Periods: During summer months (high temperature + Ramadan fasting), GCC blood banks may face component shortages. Nurses should flag elective transfusions early and communicate with blood bank proactively.
Mandatory Transfusion-Transmitted Infection (TTI) Testing in GCC
PathogenTest MethodGCC Requirement
HIV-1 & HIV-24th Generation Ag/Ab ELISA + NAT (Nucleic Acid Testing)Mandatory — all donations; NAT shortens window period to ~9 days
Hepatitis B (HBsAg + anti-HBc)ELISA + HBV NATMandatory — HBV surface antigen + core antibody screening; HBV NAT in most GCC centres
Hepatitis C (anti-HCV)ELISA + HCV NATMandatory — NAT reduces window period to ~9 days from symptom onset
Syphilis (Treponema pallidum)TPHA / RPR serologyMandatory — serological testing standard across all GCC blood banks
MalariaMalaria antibody (ELISA) or RDT; PCR in some centresMandatory testing in GCC given large expat population from malaria-endemic regions (Indian subcontinent, Africa, SE Asia)
HTLV-I/IIELISASome GCC centres (especially Saudi Arabia) — not universal
CMVAnti-CMV serologyUsed to select CMV-negative units; universal leucodepletion used as alternative in UAE/Saudi
NAT Technology: GCC blood banks have invested heavily in NAT screening. Saudi Arabia's King Faisal Specialist Hospital and UAE's Abu Dhabi Blood Services use multiplex NAT (HIV/HCV/HBV in a single run), significantly reducing residual risk to near-negligible levels.
Halal Considerations in Blood Transfusion

Permissibility Under Islamic Law

The overwhelming consensus of Islamic scholars (including Dar al-Ifta in Saudi Arabia, UAE Fatwa Council) is that blood transfusion is permissible (mubah or even wajib — obligatory) when life is at risk. The principle of darura (necessity) overrides the general prohibition on blood under Islamic law.

Porcine Gelatin in Blood Bags

Some blood bag manufacturers historically used porcine-derived gelatin as a lubricant or component in plasticisers. However:

  • Modern PVC blood bags (Fenwal, Baxter, Fresenius Kabi) do not contain porcine gelatin in the bag walls or anticoagulant solutions (CPDA-1, SAG-M)
  • The anticoagulant-preservative solutions (citrate, dextrose, adenine, mannitol) are synthetic — no animal origin
  • GCC blood banks source bags from suppliers who can provide halal certification or confirm porcine-free manufacturing
  • If patient has concerns, reassurance about the manufacturing process is appropriate. Scholars confirm the transformation of any porcine derivative renders it permissible.
Sickle Cell & Thalassaemia in GCC — Extended Antigen Matching

GCC has among the world's highest prevalence of sickle cell disease (SCD) and beta-thalassaemia, particularly in Saudi Arabia (Eastern Province), Bahrain, Oman, and Qatar.

Alloimmunisation Risk

Repeated transfusions in SCD/thalassaemia patients leads to alloantibody formation (up to 30% in SCD). Extended phenotype matching significantly reduces this.

Minimum Match Requirements (GCC Practice)

Patient GroupMinimum Antigens Matched
All SCD/thalassaemia patientsABO, Rh (D, C, E), Kell (K)
Chronically transfused / alloimmunised+ Kidd (Jk), Duffy (Fy), MNS (S, s)
Haematopoietic stem cell transplant candidatesFull extended phenotype or molecular typing
Nurses must document "extended match required" on blood orders for known SCD/thalassaemia patients. Early ordering (24–48h before needed) allows blood bank time to source matched units.
CBAHI & JCIA Transfusion Standards — Key Requirements

CBAHI (Saudi Arabia)

  • Transfusion committee in every hospital with transfusion service
  • Quarterly audit of transfusion practice
  • Mandatory haemovigilance reporting to Saudi FDA
  • Nursing competency assessment for transfusion annually
  • Blood warmer policy for neonates and massive transfusion
  • Pre-transfusion verification policy — two-person check documented

JCIA (International)

  • International Patient Safety Goal 1 — patient identification applies to all blood administration
  • Medication Management (MMU) chapter covers blood products
  • Informed consent standard — documented prior to transfusion
  • Adverse event reporting — RCA for all serious reactions
  • Staff education and competency requirements
  • Blood bank quality management and proficiency testing

Phenotypically Matched Blood for Frequent Transfusers

  • GCC haematology centres (KFSH Riyadh, HMC Doha, SKMC Abu Dhabi) maintain extended phenotype registries
  • Donor recruitment targeting Arab donors with common Rh phenotypes reduces supply challenges
  • Molecular blood typing (DNA-based) increasingly available
  • Nurses should identify frequent transfusion patients and flag to blood bank at ordering stage